Log In
Print
BCIQ
Print
Print this Print this
 

Loulla, mercaptopurine

  Manage Alerts
Collapse Summary General Information
Company Only for Children Pharmaceuticals S.A.S.
DescriptionOral formulation of mercaptopurine, a DNA synthesis inhibitor
Molecular Target
Mechanism of ActionDNA synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAcute lymphoblastic leukemia (ALL)
Indication DetailsMaintenance treatment for acute lymphoblastic leukemia (ALL)
Regulatory Designation

U.S. - Orphan Drug (Maintenance treatment for acute lymphoblastic leukemia (ALL));
EU - Orphan Drug (Maintenance treatment for acute lymphoblastic leukemia (ALL))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today